KoreaTimes(779) - Bio, Business, page 1

Entertainment
& Arts

Sports

Beijing Olympics

World

SCMP
Asia

Video

Photos

Site Map E-paper Subscribe Register LogIn
Site Map E-paper Subscribe Register LogIn

Business

Bio

Thu, January 20, 2022 | 08:14

Samsung Biologics to begin operations of 4th plant this year

Partial operations will begin in October of this year at Samsung Biologics' fourth plant currently being built in Songdo, west of Seoul. The move is part of efforts by the drug-manufacturing unit of Samsung Group to improve its capabilities in the contract manufacturing organization (CMO) business, its CEO said Thursday.

Baek Byung-yeul | 2022-01-13 16:24

Novavax COVID-19 vaccine gets approval

A worker is seen at SK Bioscience's plant manufacturing the COVID-19 vaccine of U.S. biotech company Novavax in Andong, North Gyeongsang Province, in this photo. The Ministry of Food and Drug Safety on Wednesday authorized the use of Novavax's COVID-19 vaccine.

Kim Bo-eun | 2022-01-12 17:28

Nanocovax COVID-19 vaccine proven effective

Nanocovax, a COVID-19 vaccine developed by Vietnamese biotech company Nanogen, has received confirmation of its safety and effectiveness, paving its way to the global biopharmaceutical market, Korean biotech company HLB said Monday.

Baek Byung-yeul | 2021-12-20 16:17

Samsung, SK responding to Omicron COVID-19 variant

Samsung Biologics, SK Bioscience, Celltrion, Seegene and other Korean biotech firms are responding to the latest COVID-19 variant called Omicron at a time when the new mutation could become an even greater concern than the Delta variant, according to companies Wednesday.

Baek Byung-yeul | 2021-12-01 17:05

Seegene test kits capable of detecting Omicron variant

With the global community facing the spread of the Omicron variant of COVID-19, Korean biotechnology company Seegene said Wednesday that its test kit is fully able to detect the new mutation.

Baek Byung-yeul | 2021-12-01 11:18

SCM Lifesciences appoints founder Song as CEO again

SCM Lifescience appointed its founder and chief strategy officer (CSO) Song Sun-uk as its new CEO, Monday.

Anna J. Park | 2021-11-15 15:40

Celltrion's COVID-19 antibody treatment wins EU drug agency's recommendation

The European Union's drug agency has recommended the approval of a COVID-19 antibody treatment by Celltrion, paving the way for its sales in the region, the South Korean pharmaceutical giant said Friday.

2021-11-12 14:28

EU watchdog backs two COVID antibody treatments

CJ remains upbeat over approval for Batavia acquisition

A few days after CJ Group - a mid-tier conglomerate in Korea focused on food and beverages - said it plans to invest up to 10 trillion won until 2023, its entertainment affiliate said it is about to enter the highly-lucrative biopharma CDMO business.

Kim Yoo-chul | 2021-11-09 15:17

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.